We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$45.3M
2
MDVN
MEDIVATION, INC.
MDVN
+$33.2M
3
DHR icon
Danaher
DHR
+$28.3M
4
FLTX
Fleetmatics Group PLC
FLTX
+$25.2M
5
HCSG icon
Healthcare Services Group
HCSG
+$24.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEG icon
901
Public Service Enterprise Group
PEG
$38.2B
$390K ﹤0.01%
9,321
+648
+7% +$28.5K
SPWR
902
DELISTED
SunPower Corporation Common Stock
SPWR
$390K ﹤0.01%
66,689
-64,676
-49% -$502K
TLP
903
DELISTED
Transmontaigne
TLP
$390K ﹤0.01%
9,458
+174
+2% +$7.28K
BTI icon
904
British American Tobacco
BTI
$128B
$389K ﹤0.01%
6,092
-748
-11% -$47.4K
IEX icon
905
IDEX
IEX
$17.2B
$389K ﹤0.01%
4,161
-356
-8% -$32.1K
DXCM icon
906
CALL
DexCom
DXCM
$32.9B
$386K ﹤0.01%
+17,600
New +$392K
MNST icon
907
Monster Beverage
MNST
$91.5B
$384K ﹤0.01%
15,690
-2,082
-12% -$54K
MTCH icon
908
Match Group
MTCH
$9.46B
$384K ﹤0.01%
21,595
+2,620
+14% +$41.9K
RBC icon
909
RBC Bearings
RBC
$18.1B
$383K ﹤0.01%
5,005
-213
-4% -$16.3K
AAMI
910
Acadian Asset Management
AAMI
$3.2B
$383K ﹤0.01%
27,507
+2,840
+12% +$38.5K
MGA icon
911
Magna International
MGA
$18.2B
$381K ﹤0.01%
8,871
+200
+2% +$7.88K
MCY icon
912
Mercury Insurance
MCY
$5.94B
$380K ﹤0.01%
6,935
+500
+8% +$27K
WFC.PRL icon
913
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
$379K ﹤0.01%
291
-19
-6% -$25.5K
XCRA
914
DELISTED
Xcerra Corporation
XCRA
$379K ﹤0.01%
62,593
– –
SPH icon
915
Suburban Propane Partners
SPH
$1.25B
$376K ﹤0.01%
11,294
+624
+6% +$21K
SAN icon
916
Banco Santander
SAN
$206B
$375K ﹤0.01%
88,696
+1,921
+2% +$7.85K
MMSI icon
917
Merit Medical Systems
MMSI
$5.11B
$374K ﹤0.01%
15,399
– –
SNY icon
918
Sanofi
SNY
$103B
$374K ﹤0.01%
9,782
+34
+0.3% +$1.36K
CASS icon
919
Cass Information Systems
CASS
$722M
$373K ﹤0.01%
8,700
-845
-9% -$34.7K
ES icon
920
Eversource Energy
ES
$27.1B
$369K ﹤0.01%
6,809
-898
-12% -$50.7K
DRI icon
921
Darden Restaurants
DRI
$23.6B
$367K ﹤0.01%
5,987
+21
+0.4% +$1.3K
IVE icon
922
iShares S&P 500 Value ETF
IVE
$49.8B
$367K ﹤0.01%
3,860
+399
+12% +$38K
VV icon
923
Vanguard Morningstar Large-Cap ETF
VV
$54.2B
$367K ﹤0.01%
3,699
+1,380
+60% +$137K
INDA icon
924
iShares MSCI India ETF
INDA
$6.65B
$366K ﹤0.01%
12,439
-627
-5% -$18.4K
SWC
925
DELISTED
Stillwater Mining Co
SWC
$366K ﹤0.01%
27,369
-3,420
-11% -$45.9K
35 36
37
38 39

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.